))
PRRT (Part Two) with Dr. Martin Auerbach
Manage episode 349899331 series 3426844
内容由Learn Advocate Connect Neuroendocrine Tumor Society提供。所有播客内容（包括剧集、图形和播客描述）均由 Learn Advocate Connect Neuroendocrine Tumor Society 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品，您可以按照此处概述的流程进行操作https://zh.player.fm/legal。
Who is eligible for PRRT? What are the side effects? Should somatostatin analogues be continued? Can PRRT be repeated when there is disease progression? NET expert and Nuclear Medicine Physician Dr. Martin Auerbach of UCLA Health answers 10 common questions about the decision-making process of PRRT. Dr. Auerbach addresses how to manage side effects, carcinoid crisis, labs, and post-PRRT imaging. Listen now!
Be sure to listen to Episode 8: PRRT (Part One) with Administrative Nurse Lindy Gardner of UCLA Health.
For more information, visit LACNETS.org.
42集单集
分享
